SMMT

Summit Therapeutics
D

SMMT

14.970
USD
0.22
(1.49%)
مغلق
حجم التداول
119,925
الربح لكل سهم
-1
العائد الربحي
-
P/E
-9
حجم السوق
11,619,154,796
أصول ذات صلة المقالات
المزيد

العنوان: Summit Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate isridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.